Type 1 Diabetes Archives - Endocrinology Advisor

In a 2006 meta-analysis published in JAMA investigating the impact of strategic quality improvement on glycemic control among adults with type 2 diabetes, researchers found that the use of multidisciplinary care teams, shared care between primary care physicians and specialists, and effective case management led to reductions in HbA1c by at least 0.5%.3 Additional positive outcomes of care team management include increased patient satisfaction, improved quality of life, fewer hospitalizations, decreased health care costs, and lower risks for diabetes complications.1

Diabetes

Type 1 Diabetes Glycemic Control Improved During Pandemic Lockdown

January 14, 2021

On average, glycemic control improved during lockdown among people living with type 1 diabetes.

Diabetes

FDA Approves First Generic Version of Glucagon Emergency Kit

By

Brian Park, PharmD

January 5, 2021

The FDA has approved the first generic equivalent of Glucagon Emergency Kit (Lilly), according to Amphastar Pharmaceuticals.

Diabetes

Physicians Call for Revised Staging System for Diabetic Retinal Diseases

By

Jodi McCaffrey, MA, FACHE

December 18, 2020

Investigators advocate for a staging system that keeps pace with the current body of knowledge.

Diabetes

Diabetic Retinopathy May Increase Risk for COVID-19 Intubation

December 4, 2020

For patients with diabetes hospitalized with COVID-19, the risk for intubation is increased more than fivefold for those with diabetic retinopathy.

Diabetes

Nephropathy Progression in Type 1 Diabetes Linked to Depression

By

Jody A. Charnow

November 25, 2020

Whether successful treatment of depression reduces the risk for progression needs to be determined.

Diabetes

Sotagliflozin Reduces Risk for Adverse CV Events in Diabetic Kidney Disease

By

Natasha Persaud

November 25, 2020

Sotagliflozin might help patients with diabetes and chronic kidney disease who are hospitalized with heart failure avoid a readmission, study results suggest.

Diabetes

Group-Based Lifestyle Intervention Reduces T2DM Progression

November 25, 2020

A low-cost, group-delivered lifestyle intervention is associated with a significantly lower risk for progression to type 2 diabetes among high-risk individuals.

Type 1 Diabetes

Younger Age, Female Sex, and HbA1c Linked to C-Peptide Decline in Pediatric T1D

By

Corinna Panlilio Sison, MD

November 12, 2020

Investigators sought to determine whether younger age at diagnosis, female sex, and higher weight z score and HbA1c are risk factors for C-peptide decline after new onset of pediatric type 1 diabetes.

Diabetes

Real-Time CGM Improves Hypoglycemia-Related Glucose Control

By

Amit Akirov, MD

November 10, 2020

The study goal was to determine whether real-time continuous glucose monitoring up to 24 months is beneficial, particularly in persons living with impaired awareness of hypoglycemia.

Diabetes

Teplizumab BLA for Tyoe 1 Diabetes Prevention Submitted

By

Brian Park, PharmD

November 5, 2020

The BLA is supported by data from a phase 2 trial that evaluated whether teplizumab could prevent or delay the onset of T1D in at-risk individuals.